Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder

Psychoneuroendocrinology

Volumn 29, Issue 6, 2004, Pages 767-777

  Nyberg, Sigrid ^a   Wahlström, Göran ^a   Bäckström, Torbjörn ^a   Poromaa, Inger Sundström ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcohol; Clinical trial; Menstrual cycle; Premenstrual dysphoric disorder; Saccadic eye velocity

Indexed keywords

ALCOHOL ABUSE; ALCOHOL INTOXICATION; ALCOHOL TOLERANCE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECELERATION; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; OPTOMETRY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RISK FACTOR; SACCADIC EYE MOVEMENT; SELF CONCEPT;

ADULT; ALCOHOLIC INTOXICATION; ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOUBLE-BLIND METHOD; ESTRADIOL; ETHANOL; FEMALE; FOLLICULAR PHASE; HUMANS; INFUSIONS, INTRAVENOUS; LUTEAL PHASE; MIDDLE AGED; PREMENSTRUAL SYNDROME; PROGESTERONE; REFERENCE VALUES; SACCADES;

EID: 1942509460     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00121-5     Document Type: Article

References (53)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. 1994;714-718 US Department of Health and Human Services, Washington DC.
2. Arden G.B., Wolf J.E. The electro-oculographic responses to alcohol and light in a series of patients with retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 41:2000;2730-2734.
3. Ator N.A., Grant K.A., Purdy R.H., Paul S.M., Griffiths R.R. Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur. J. Pharmacol. 241:1993;237-243.
4. Bäckström T., Sanders D., Leask R., Davidson D., Warner P., Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom. Med. 45:1983;503-507.
5. Baloh R.W., Sills A.W., Kumley W.E., Honrubia V. Quantitative measurement of saccade amplitude, duration, and velocity. Neurology. 25:1975;1065-1070.
6. Bethea C.L., Pecins-Thompson M., Schutzer W.E., Gundlah C., Lu Z.N. Ovarian steroids and serotonin neural function. Mol. Neurobiol. 18:1998;87-123.
7. Bixo M., Andersson A., Winblad B., Purdy R.H., Bäckström T. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20- one in specific regions of the human female brain in different endocrine states. Brain Res. 764:1997;173-178.
8. Brick J., Nathan P.E., Westrick E., Frankenstein W., Shapiro A. The effect of menstrual cycle on blood alcohol levels and behavior. J. Stud. Alcohol. 47:1986;472-477.
9. Caan B., Duncan D., Hiatt R., Lewis J., Chapman J., Armstrong M.A. Association between alcoholic and caffeinated beverages and premenstrual syndrome. J. Reprod. Med. 38:1993;630-636.
10. Centralförbundet för alkohol och narkotikaupplysning, 2002. Trends in alcohol and other drugs in Sweden, in: Guttormsson, U. (Ed.), Stockholm, Rapport nr 68, pp. 67-110.
11. Charette L., Tate D.L., Wilson A. Alcohol consumption and menstrual distress in women at higher and lower risk for alcoholism. Alcohol Clin. Exp. Res. 14:1990;152-157.
12. Christensen A.P., Oei T.P., Callan V.J. The relationship between premenstrual dysphoria and daily ratings dimensions. J. Affect. Disord. 16:1989;127-132.
13. Chuong C.J., Burgos D.M. Medical history in women with premenstrual syndrome. J. Psychosom. Obstet. Gynaecol. 16:1995;21-27.
14. Cohen H.L., Porjesz B., Stimus A.T., Begleiter H. Effects of ethanol on temporal recovery of auditory-evoked potentials in individuals at risk for alcoholism. Alcohol Clin. Exp. Res. 22:1998;945-953.
15. Davidson D., Camara P., Swift R. Behavioral effects and pharmacokinetics of low-dose intravenous alcohol in humans. Alcohol Clin. Exp. Res. 21:1997;1294-1299.
16. Devaud L.L., Purdy R.H., Morrow A.L. The neurosteroid, 3α-hydroxy-5α-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin. Exp. Res. 19:1995;350-355.
17. Eckhardt M.J., File S.E., Gessa G.L., Grant K.A., Guerri C., Hoffman P.L., Kalant H., Koob G.F., Li T.-K., Tabakoff B. Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin. Exp. Res. 22:1998;998-1040.
18. Grant K.A., Azarov A., Bowen C.A., Mirkis S., Purdy R.H. Ethanol-like discriminative stimulus effects of the neurosteroid 3α-hydroxy-5α- pregnan-20-one in female Macaca fascicularis monkeys. Psychopharmacology. 124:1996;340-346.
19. Halbreich U., Piletz J.E., Carson S., Halaris A., Rojansky N. Increased imidazoline and α2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol. Psychiatry. 34:1993;676-686.
20. Halbreich U., Tworek H. Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int. J. Psychiatry Med. 23:1993;1-27.
21. Halliday A., Bush B., Cleary P., Aronson M., Delbanco T. Alcohol abuse in women seeking gynecologic care. Obstet. Gynecol. 68:1986;322-326.
22. Hammarbäck S., Bäckström T. Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet. Gynecol. Scand. 67:1988;159-166.
23. Hammarbäck S., Bäckström T., MacGibbon-Taylor B. Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J. Psychosom. Obstet. Gynaecol. 10:1989;25-42.
24. Hammarbäck S., Ekholm U.B., Bäckström T. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol. (Copenh.). 125:1991;132-137.
25. Holdstock L., de Wit H. Ethanol impairs saccadic and smooth pursuit eye movements without producing self-reports of sedation. Alcohol Clin. Exp. Res. 23:1999;664-672.
26. Holdstock L., de Wit H. Effects of ethanol at four phases of the menstrual cycle. Psychopharmacology. 150:2000;374-382.
27. Hommer D.W., Matsuo V., Wolkowitz O., Chrousos G., Greenblatt D.J., Weingartner H., Paul S.M. Benzodiazepine sensitivity in normal human subjects. Arch. Gen. Psychiatry. 43:1986;542-551.
28. Jones B.M., Jones M.K. Alcohol effects in women during the menstrual cycle. Ann. N. Y. Acad. Sci. 273:1976;576-587.
29. Jäntti V., Lang A.H., Keskinen E., Lehtinen I., Pakkanen A. Acute effects of intravenously given alcohol on saccadic eye movements and subjective evaluations of intoxication. Psychopharmacology. 79:1983;251-255.
30. Konrad H.R. Clinical application of saccade-reflex testing in man. Laryngoscope. 101:1991;1293-1302.
31. Korkmaz S., Wahlström G. The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats. Brain Res. Protocols. 1:1997;378-384.
32. A receptor function: molecular and physiological determinants. Biggio G., Costa E. GABAergic Synaptic Transmission. 1992;269-279 Raven Press, New York.
33. Linnoila M., Erwin C.W., Ramm D., Cleveland W.P., Brendle A. Effects of alcohol on psychomotor performance of women: interaction with menstrual cycle. Alcohol Clin. Exp. Res. 4:1980;302-305.
34. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
35. Marshall R.W., Griffiths A.N., Richens A. A microcomputer system to assess CNS depression from the analysis of the dynamics of saccadic eye movements. Br. J. Clin. Pharmacol. 20:1985;304-305.
36. Marshall R.W., Richens A. An IBM-based system for the generation, collection and analysis of saccadic and smooth pursuit eye movements. Br. J. Clin. Pharmacol. 28:1989;752-753.
37. McLeod D.R., Foster G.V., Hoehn-Saric R., Svikis D.S., Hipsley P.A. Family history of alcoholism in women with generalized anxiety disorder who have premenstrual syndrome. Alcohol Clin. Exp. Res. 18:1994;664-670.
38. Melchior C.L., Allen P.M. Interaction of pregnanolone and pregnenolone sulfate with ethanol and pentobarbital. Pharmacol. Biochem. Behav. 42:1992;605-611.
39. Mumenthaler M.S., O'Hara R., Taylor J.L., Friedman L., Yesavage J.A. Influence of the menstrual cycle on flight simulator performance after alcohol ingestion. J. Stud. Alcohol. 62:2001a;422-433.
40. Mumenthaler M.S., O'Hara R., Taylor J.L., Friedman L., Yesavage J.A. Relationship between variations in estradiol and progesterone levels across the menstrual cycle and human performance. Psychopharmacology. 155:2001b;198-203.
41. Niaura R.S., Nathan P.E., Frankenstein W., Shapiro A.P., Brick J. Gender differences in acute psychomotor, cognitive, and pharmacokinetic response to alcohol. Addict. Behav. 12:1987;345-356.
42. Pearson P., Timney B. Effects of moderate blood alcohol concentrations on spatial and temporal contrast sensitivity. J. Stud. Alcohol. 59:1998;163-173.
43. Peindl K.S., Wisner K.L., Hanusa B.H. Alcohol dependency and affective illness among women of childbearing age. Arch. Womens Ment. Health. 1:1998;117-123.
44. Rapkin A.J. Progesteron, GABA and mood disorder in women. Arch. Womens Ment. Health. 2:1999;97-105.
45. Roy-Byrne P., Cowley D.S., Greenblatt D.J., Shader R.I., Hommer D. Reduced benzodiazepine sensitivity in panic disorder. Arch. Gen. Psychiatry. 47:1990;534-538.
46. Stout A.L., Steege J.F., Blazer D.G., George L.K. Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. J. Nerv. Ment. Dis. 174:1986;517-522.
47. Sundström I., Ashbrook D., Bäckström T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome, a pilot study. Psychoneuroendocrinology. 22:1997;25-38.
48. Sundström I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., Bäckström T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology. 67:1998;126-138.
49. Sundström I., Nyberg S., Bixo M., Hammarbäck S., Bäckström T. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet. Gynecol. Scand. 78:1999;891-899.
50. Sutker P.B., Goist K.C. Jr., King A.R. Acute alcohol intoxication in women: relationship to dose and menstrual cycle phase. Alcohol Clin. Exp. Res. 11:1987;74-79.
51. Tobin M.B., Schmidt P.J., Rubinow D.R. Reported alcohol use in women with premenstrual syndrome. Am. J. Psychiatry. 151:1994;1503-1504.
52. Wang M., Seippel L., Purdy R.H., Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome. Study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J. Clin. Endocrinol. Metab. 81:1996;1076-1082.
53. Wang M.D., Zhu D., Bäckström T., Wahlström G. The interaction between ethanol and pregnanolone at induction of anesthesia investigated with a threshold method in male rats. Br. J. Pharmacol. 134:2001;1393-1402.